Ausführlicher Leitfaden kommt bald
Wir arbeiten an einem umfassenden Bildungsleitfaden für den FFP Dose Calculator. Schauen Sie bald wieder vorbei für Schritt-für-Schritt-Erklärungen, Formeln, Praxisbeispiele und Expertentipps.
Fresh Frozen Plasma (FFP) is a blood product derived from whole blood or apheresis that contains all clotting factors, von Willebrand factor, fibrinogen, albumin, and other plasma proteins in physiological concentrations. It is frozen within 8 hours of collection to preserve labile coagulation factors V and VIII, which rapidly degrade at room temperature. FFP is indicated to replace multiple coagulation factor deficiencies when specific factor concentrates are unavailable — principally in disseminated intravascular coagulation (DIC), liver disease coagulopathy, massive transfusion-related dilutional coagulopathy, and occasionally in warfarin reversal when prothrombin complex concentrate (PCC) is not available. The standard adult dose is 10–15 mL/kg, which typically equates to 2–4 standard units (each unit approximately 200–300 mL in the UK, 250–300 mL in the US). This dose is expected to raise coagulation factor levels by approximately 15–20%, which is usually sufficient to achieve haemostasis. FFP requires ABO compatibility (though not full cross-matching) and takes 20–30 minutes to thaw from frozen, which can delay administration in acute haemorrhage — a critical operational consideration. Over the past decade, prothrombin complex concentrate (PCC) has largely replaced FFP for warfarin reversal due to faster administration, smaller volume, lack of thawing requirement, and lower risk of TACO and TRALI. Nevertheless, FFP remains indispensable where specific factor concentrates are unavailable or where the full spectrum of factor replacement is needed, such as in TTP (thrombotic thrombocytopenic purpura) where it provides ADAMTS13 enzyme.
FFP Dose (mL) = 10–15 mL/kg × Patient Weight (kg) Units required = Total volume (mL) / Volume per unit (~250 mL) Expected factor rise = ~15–20% increase per dose
- 1Confirm the indication for FFP: active bleeding with PT/APTT >1.5× normal, DIC, liver disease coagulopathy, TTP, or dilutional coagulopathy in massive transfusion.
- 2Record patient weight in kilograms to calculate the dose: 10–15 mL/kg.
- 3Calculate total volume: multiply weight by 10–15 mL/kg. Divide by the volume per unit (approximately 250 mL) to determine number of units.
- 4Request ABO-compatible FFP from the blood bank; note that thawing takes 20–30 minutes — order early in anticipated haemorrhage.
- 5Administer FFP through a standard blood administration set. Typical infusion rate is 10–20 mL/minute for adults.
- 6Recheck PT/INR and APTT 15–30 minutes after completing the infusion to assess response.
- 7Repeat dosing as needed based on laboratory response and ongoing clinical haemorrhage. In DIC, treat the underlying cause simultaneously.
Check PT/INR post-infusion; target INR <1.5 for procedures
Liver disease impairs synthesis of all clotting factors except vWF and factor VIII. FFP provides broad factor replacement. However, the short half-life of some factors means effect is transient, and re-checking coagulation before starting the procedure is essential.
Add cryoprecipitate for fibrinogen <1.5 g/L; treat underlying cause
DIC involves simultaneous widespread clotting and fibrinolysis, consuming all factors rapidly. FFP replaces multiple factors, but fibrinogen is often severely depleted and requires cryoprecipitate (10 units raises fibrinogen by ~1 g/L). Treating the precipitant — sepsis, obstetric emergency, malignancy — is the definitive intervention.
PCC strongly preferred if available; give IV vitamin K 10 mg concurrently
FFP can reverse warfarin coagulopathy but takes 30+ minutes to thaw, delivers a large fluid volume, and provides lower factor concentrations than PCC. If PCC is unavailable, 4 factor PCC dose should be estimated by INR-weight nomogram. IV vitamin K 10 mg ensures sustained reversal as FFP factors are metabolised.
TTP requires plasma exchange with FFP as the replacement fluid
In TTP, deficiency of ADAMTS13 leads to ultra-large vWF multimers causing microvascular thrombosis. Therapeutic plasma exchange (TPE) removes auto-antibodies and abnormal vWF, while FFP replenishes ADAMTS13. The volume required for TPE far exceeds standard dosing.
Mortgage lenders and loan officers use Ffp Dose to structure repayment schedules, compare fixed versus adjustable rate options, and calculate total borrowing costs for residential and commercial real estate transactions across different term lengths.
Personal finance advisors apply Ffp Dose when counseling clients on debt reduction strategies, comparing the mathematical benefit of accelerated payments against alternative investment returns to determine the optimal allocation of surplus cash flow.
Credit unions and community banks rely on Ffp Dose to generate accurate Truth in Lending disclosures, ensure regulatory compliance with TILA and RESPA requirements, and provide borrowers with standardized cost comparisons across competing loan products.
Corporate treasury departments use Ffp Dose to model the cost of revolving credit facilities, term loans, and commercial paper programs, optimizing the company's capital structure and minimizing weighted average cost of debt financing.
Zero or negative interest rate
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in ffp dose calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Balloon payment at maturity
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in ffp dose calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Variable rate mid-term adjustment
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in ffp dose calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Cardiac and Renal Failure — TACO Risk
Patients with heart failure or oliguric renal failure are at high risk for fluid overload from FFP. Consider furosemide pre-medication, use the minimum effective dose, administer slowly, and consider PCC as an alternative where appropriate to minimise volume load.
| Indication | Dose | Alternative | Notes |
|---|---|---|---|
| DIC | 15 mL/kg | Cryoprecipitate (fibrinogen) | Treat underlying cause |
| Liver disease coagulopathy | 10–15 mL/kg | PCC (if available) | Effect transient; repeat as needed |
| Warfarin reversal | 10–15 mL/kg | 4-factor PCC (preferred) | Add IV vitamin K 10 mg |
| Massive transfusion | 1:1 ratio with pRBC | Whole blood (trauma centres) | Balanced resuscitation protocol |
| TTP (plasma exchange) | 40 mL/kg as replacement fluid | Solvent/detergent plasma | 1–1.5 plasma volumes exchanged |
When should FFP be used versus prothrombin complex concentrate (PCC)?
PCC is preferred for warfarin reversal because it is faster to administer (no thawing), delivers higher factor concentrations in smaller volume, and has lower risk of TACO and TRALI. FFP is preferred when multiple factor deficiencies beyond those covered by PCC need replacement (e.g., DIC, liver disease, dilutional coagulopathy) or when PCC is unavailable.
Does FFP need to be ABO compatible?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
How long does it take to thaw FFP?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
What is the difference between FFP and cryoprecipitate?
Ffp Dose is a specialized calculation tool designed to help users compute and analyze key metrics in the finance and lending domain. It takes specific numeric inputs — typically drawn from real-world data such as measurements, rates, or quantities — and applies a validated mathematical formula to produce actionable results. The tool is valuable because it eliminates manual calculation errors, provides instant feedback when exploring different scenarios, and serves as both a decision-support instrument for professionals and a learning aid for students studying the underlying principles.
Can FFP be used prophylactically before invasive procedures?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
What are the main risks of FFP transfusion?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
How soon after administration does FFP take effect?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
Is FFP effective in massive transfusion protocol?
In the context of Ffp Dose, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of finance and lending practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
Profi-Tipp
In any bleeding patient with coagulopathy, request a viscoelastic haemostasis assay (VHA — ROTEM or TEG) if available alongside PT/APTT. VHA provides real-time, comprehensive information about clot formation, strength, and lysis, allowing targeted use of FFP, cryoprecipitate, platelets, and tranexamic acid rather than empirical use of all products.
Wussten Sie?
Fresh Frozen Plasma was first developed during World War II when plasma was used as a battlefield substitute for whole blood. Because it could be freeze-dried, stored at room temperature, and reconstituted with sterile water, it could be transported to frontline medical units far more easily than fresh blood — saving thousands of lives before blood banking became widespread.
Referenzen
- ›National Institute for Health and Care Excellence. Blood transfusion (NG24). NICE guideline. 2015.
- ›Liumbruno G et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus. 2009;7(2):132-150.
- ›Spahn DR et al. Management of bleeding and coagulopathy following major trauma. Crit Care. 2019;23:98.
- ›Srivastava A et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1-158.